Bicara Therapeutics Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-09-30 | 2023-12-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -20,613 | -25,764 |
EBIT | -20,628 | -25,778 |
Net Income | -17,481 | -12,440 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -17,232 | -8,472 |
Cash | 520,758 | 230,440 |
Basic Shares | 54,409 | 53,085 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -51,961 | -37,722 |
EBIT | -51,980 | -37,732 |
Net Income | -51,985 | -37,845 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -46,214 | -32,268 |
Cash | 230,440 | 4,158 |
Basic Shares | 51,760 | 51,760 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.32 |
